NCT01791062View on ClinicalTrials.gov

Safety and Efficacy Study of HYTOP® in the Treatment of Focal Chondral Defects.

NACompletedINTERVENTIONAL
Enrollment

2

Participants

Timeline

Start Date

February 28, 2014

Primary Completion Date

October 31, 2016

Study Completion Date

October 31, 2016

Conditions
Focal Chondral Defect in Femoro-tibial Compartment of the Knee Joint
Interventions
DEVICE

HYTOP®

HYTOP® will be implanted once during surgery.

Trial Locations (1)

49076

Klinikum Osnabrück GmbH Finkenhügel, Klinik für Orthopädie, Unfall- und Handchirurgie, Osnabrück

All Listed Sponsors
lead

TRB Chemedica AG

INDUSTRY

NCT01791062 - Safety and Efficacy Study of HYTOP® in the Treatment of Focal Chondral Defects. | Biotech Hunter | Biotech Hunter